國家衛生研究院 NHRI:Item 3990099045/3091
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 859736      線上人數 : 798
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/3091


    題名: On statistical evaluation of the linearity in assay validation
    作者: Hsieh, E;Liu, JP
    貢獻者: Division of Biostatistics and Bioinformatics
    摘要: Linearity is one of the most important characteristics for evaluation of the accuracy in assay validation. The current statistical method for evaluation of the linearity recommended by the Clinical Laboratory Standard Institute (CLSI) guideline EP6-A is reviewed. The method directly compares the point estimates with the pre-specified allowable limit and completely ignores the sampling error of the point estimates. An alternative method for evaluation of linearity, proposed by Kroll et al. (2000), considers the statistical test procedure based on the average deviation from linearity (ADL). However this procedure is based on an inappropriate formulation of hypotheses for the evaluation of linearity. Consequently, the type I error rates of both current methods may be inflated for inference of linearity. To claim the linearity of analytical methods, we propose that the hypothesis of proving the linearity should be formulated as the alternative hypothesis. Furthermore, any procedures for assessment of linearity should be based on the sampling distributions of the proposed test statistics. Therefore, we propose a two one-sided test (TOST) procedure and a corrected Kroll's procedure. The simulation studies were conducted to empirically compare the size and power between current and proposed methods. The simulation results show that the proposed methods not only adequately control size but also provide sufficient power. A numeric example illustrates the proposed methods.
    關鍵詞: Pharmacology & Pharmacy;Statistics & Probability
    日期: 2008
    關聯: Journal of Biopharmaceutical Statistics. 2008;18(4):677-690.
    Link to: http://dx.doi.org/10.1080/10543400802071378
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1054-3406&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000257438900009
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=46749157535
    顯示於類別:[劉仁沛(1998-2002)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    000257438900009.pdf140KbAdobe PDF520檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋